Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;20(10):938-943.
doi: 10.2174/0115734064287956240426110450.

In vitro and In vivo Biological Activity of Two Aryloxy-naphthoquinones in Mice Infected with Trypanosoma cruzi Strains

Karina Vázquez  1 , Adriana Moreno-Rodríguez  2 , Luis R Domínguez-Díaz  2 , Jeanluc Bertrand  3 , Cristian O Salas  3 , Gildardo Rivera  4 , Yobana Pérez Cervera  5 , Virgilio Bocanegra-García  4
Affiliations

In vitro and In vivo Biological Activity of Two Aryloxy-naphthoquinones in Mice Infected with Trypanosoma cruzi Strains

Karina Vázquez et al. Med Chem. 2024.

Abstract

Background: Chagas disease, a condition caused by Trypanosoma cruzi, is an endemic disease in Latin American countries that affects approximately eight million people worldwide. It is a continuing public health problem. As nifurtimox and benznidazole are the two pharmacological treatments currently used to treat it, the present research proposes new therapeutic alternatives. Previous studies conducted on naphthoquinone derivatives have found interesting trypanocidal effects on epimastigotes, with the molecules 2-phenoxy-1,4-naphthoquinone (IC50= 50 nM and SI < 250) and 2-(3-nitrophenoxy)-naphthalene-1,4-dione (IC50= 20 nM and SI=625) presenting the best biological activity..

Methods: The present study evaluated the efficacy of in vitro, ex vivo and in vivo models of two aryloxyquinones, 2-phenoxy-1,4-naphthoquinone (1) and 2-(3-nitrophenoxy)-naphthalene-1,4- dione (2), against two Mexican T. cruzi strains in both their epimastigote and blood Trypomastigote stage. Both compounds were evaluated against T. cruzi using a mouse model (CD1) infected with Mexican isolates of T. cruzi, nifurtimox and benznidazole used as control drugs. Finally, the cytotoxicity of the two compounds against the J774.2 mouse macrophage cell line was also determined.

Results: The in vitro and in vivo results obtained indicated that both quinones were more active than the reference drugs. Compound 1 presents in vivo activity, showing up to 40% parasite reduction after 8 h of administration, a finding which is 1.25 times more effective than the results obtained using nifurtimox.

Conclusion: These are encouraging results for proposing new naphthoquinone derivatives with potential anti-T. cruzi activity.

Keywords: Trypanosoma cruzi; aryloxy-naphthoquinones; in vivo assay; mouse model; naphthoquinone derivatives.; trypanosomicidal activity.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Chagas disease (American trypanosomiasis). Available from: https://www.who.int/es/news-room/fact-sheets/detail/chagas-disease-(amer...
    1. Dias J.C.P.; Schofield C.J.; The evolution of Chagas disease (American Trypanosomiasis) control after 90 years since carlos chagas discovery. Mem Inst Oswaldo Cruz 1999,94(S1),103-121 - DOI - PubMed
    1. Antiparasitic treatment. Available from: https://www.cdc. gov/parasites/chagas/health_professionals/tx.html2021
    1. Santos S.S.; de Araújo R.V.; Giarolla J.; Seoud O.E.; Ferreira E.I.; Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: A review. Int J Antimicrob Agents 2020,55(4),105906 - DOI - PubMed
    1. Filardi L.S.; Brener Z.; Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 1987,81(5),755-759 - DOI - PubMed

MeSH terms